UNIVERSITY OF MINNESOTA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.umn.edu
Grocery Assistance Program Study
Not Applicable
Completed
- Conditions
- Food Assistance
- Interventions
- Behavioral: F&V BonusBehavioral: RestrictionBehavioral: Bonus & Restriction
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 296
- Registration Number
- NCT02643576
- Locations
- 🇺🇸
University of Minnesota School of Public Health, Minneapolis, Minnesota, United States
Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease
Phase 2
Terminated
- Conditions
- Peripheral Arterial Disease
- Interventions
- Drug: Placebo groupDrug: Entresto
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 6
- Registration Number
- NCT02636283
- Locations
- 🇺🇸
University of Minnesota Medical Center, Minneapolis, Minnesota, United States
Transcranial Magnetic Stimulation for Facial Pain
Not Applicable
Completed
- Conditions
- Facial PainNervus Intermedius NeuralgiaPost-herpetic NeuralgiaTrigeminal Nerve Injuries
- Interventions
- Device: transcranial magnetic stimulation
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 9
- Registration Number
- NCT02633306
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Mindfulness-Based Yoga Intervention for Women With Depression
Not Applicable
Completed
- Conditions
- Depressive SymptomsDepression
- Interventions
- Behavioral: Mindfulness-based YogaBehavioral: Walking Control Condition
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 40
- Registration Number
- NCT02630758
Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain
Completed
- Conditions
- Temporomandibular Joint DisordersToothache
- Interventions
- Procedure: Pressure pain threshold
- First Posted Date
- 2015-12-15
- Last Posted Date
- 2019-05-02
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 39
- Registration Number
- NCT02630771
- Locations
- 🇺🇸
University of Minnesota School of Dentistry, Minneapolis, Minnesota, United States
KAM: Kids Are Moving
Not Applicable
Completed
- Conditions
- FatiguePhysical ActivityChildren With Cancer
- Interventions
- Other: Physical activity coaching
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 31
- Registration Number
- NCT02626637
- Locations
- 🇺🇸
Children's Minnesota, Minneapolis, Minnesota, United States
🇺🇸University of Minnesota Masonic Childrens, Minneapolis, Minnesota, United States
Differential Sensitivity Markers in Youth Drug Abuse Prevention
Not Applicable
Completed
- Conditions
- Adolescent Substance Use
- Interventions
- Behavioral: Teen InterveneBehavioral: Everyday Parenting
- First Posted Date
- 2015-12-04
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 32
- Registration Number
- NCT02622451
- Locations
- 🇺🇸
Center for Personalized Prevention Research in Children's Mental Health, Minneapolis, Minnesota, United States
Primed vs Unprimed Facilitatory and Depressive Paired Associative Stimulation
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: Transcranial Magnetic Stimulation (Magstim)
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 32
- Registration Number
- NCT02619643
Flavoring Oral Contrast for MR Enterography
Withdrawn
- Conditions
- Taste, Altered
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- University of Minnesota
- Registration Number
- NCT02617576
Comparison of Comparison of Ropivacaine and Liposomal Bupivacaine for Total Knee Arthroplasty
Phase 2
Withdrawn
- Conditions
- ReplacementKneeArthroplasty
- Interventions
- Drug: liposomal bupivacaine Periarticular injectionDrug: Ropivacaine Periarticular Injection
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- University of Minnesota
- Registration Number
- NCT02616367
© Copyright 2025. All Rights Reserved by MedPath